A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Phase 3

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Sponsor:

Novo Nordisk A/S

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information